Nanoscale self-assembled multivalent (SAMul) heparin binders in highly competitive, biologically relevant, aqueous media
暂无分享,去创建一个
David K. Smith | Sabrina Pricl | Paola Posocco | Jeremy E. Turnbull | Marcelo Calderón | S. Pricl | J. Turnbull | M. Calderón | P. Posocco | Stephen M. Bromfield | S. Guimond | Ching W. Chan | Scott E. Guimond | C. W. Chan | David K. Smith | C. Chan | David K. Smith | David K. Smith
[1] C. Lillehei,et al. Comparative study of polybrene and protamine for heparin neutralization in open heart surgery. , 1960, Annals of surgery.
[2] V. Aswal,et al. Dependence of the size of micelles on the salt effect in ionic micellar solutions , 2002 .
[3] M. Nowakowska,et al. Cationic derivatives of dextran and hydroxypropylcellulose as novel potential heparin antagonists. , 2011, Journal of medicinal chemistry.
[4] R. Duncan,et al. Nanomedicine(s) under the microscope. , 2011, Molecular pharmaceutics.
[5] Anna Barnard,et al. Self-assembled multivalency: dynamic ligand arrays for high-affinity binding. , 2012, Angewandte Chemie.
[6] Y. Chu,et al. Allergic shock and death associated with protamine administration in a diabetic patient. , 2010, Clinical therapeutics.
[7] C. Glass,et al. Surfen, a small molecule antagonist of heparan sulfate , 2008, Proceedings of the National Academy of Sciences.
[8] Shuhua Bai,et al. Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin. , 2007, Journal of pharmaceutical sciences.
[9] David K. Smith,et al. Heparin sensing and binding - taking supramolecular chemistry towards clinical applications. , 2013, Chemical Society reviews.
[10] A. E. Osterberg,et al. Heparin neutralization with polybrene administered intravenously. , 1958, Journal of the American Medical Association.
[11] Kinam Park,et al. Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interaction , 2010, Expert opinion on drug delivery.
[12] C. Hermans,et al. Review of the rebound phenomenon in new anticoagulant treatments , 2006, Current medical research and opinion.
[13] Sabrina Pricl,et al. Less is more – multiscale modelling of self-assembling multivalency and its impact on DNA binding and gene delivery , 2010 .
[14] Maurizio Fermeglia,et al. Mallard blue: a high-affinity selective heparin sensor that operates in highly competitive media. , 2013, Journal of the American Chemical Society.
[15] J. Engberts,et al. The use of Nile Red to monitor the aggregation behavior in ternary surfactant–water–organic solvent systems , 2005 .
[16] L. Brunsveld,et al. A supramolecular polymer as a self-assembling polyvalent scaffold. , 2009, Angewandte Chemie.
[17] D. Reinhoudt,et al. Multivalency in supramolecular chemistry and nanofabrication. , 2004, Organic & biomolecular chemistry.
[18] Christina Graf,et al. Multivalency as a chemical organization and action principle. , 2012, Angewandte Chemie.
[19] S. Middeldorp. Heparin: from animal organ extract to designer drug. , 2008, Thrombosis research.
[20] D. Rabenstein. Heparin and heparan sulfate: structure and function. , 2002, Natural product reports.
[21] Daniel J. Welsh,et al. Comparing dendritic and self-assembly strategies to multivalency--RGD peptide-integrin interactions. , 2011, Organic & biomolecular chemistry.
[22] A. Goepferich,et al. Analysis of immediate stress mechanisms upon injection of polymeric micelles and related colloidal drug carriers: implications on drug targeting. , 2012, Biomacromolecules.
[23] G. Whitesides,et al. The agglutination of erythrocytes by influenza virus is strongly inhibited by liposomes incorporating an analog of sialyl gangliosides , 1992 .
[24] Daniel W Pack,et al. Synergistic effects in gene delivery-a structure-activity approach to the optimisation of hybrid dendritic-lipidic transfection agents. , 2008, Chemical communications.
[25] M. Kikura,et al. Heparin Neutralization with Methylene Blue, Hexadimethrine, or Vancomycin After Cardiopulmonary Bypass , 1996, Anesthesia and analgesia.
[26] Maurizio Fermeglia,et al. Hydrophobically modified dendrons: developing structure-activity relationships for DNA binding and gene transfection. , 2011, Molecular pharmaceutics.
[27] P. Andrews,et al. Reversal of low-molecular-weight heparin anticoagulation by synthetic protamine analogues. , 1994, The Journal of surgical research.
[28] Francis C Szoka,et al. Biological evaluation of polyester dendrimer: poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. , 2005, Molecular pharmaceutics.
[29] Krista L. Niece,et al. Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers , 2004, Science.
[30] M. Nowakowska,et al. Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis. , 2012, European journal of pharmacology.
[31] Betty Y. S. Kim,et al. Current concepts: Nanomedicine , 2010 .
[32] D. Hoppensteadt,et al. In Vivo Neutralization of Unfractionated Heparin and Low-Molecular-Weight Heparin by a Novel Salicylamide Derivative , 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[33] Jiahai Zhang,et al. Host-guest chemistry of dendrimer-drug complexes. 5. Insights into the design of formulations for noninvasive delivery of heparin revealed by isothermal titration calorimetry and NMR studies. , 2010, The journal of physical chemistry. B.
[34] V. Vogel,et al. Analysis of the complex formation of heparin with protamine by light scattering and analytical ultracentrifugation: implications for blood coagulation management. , 2011, Journal of the American Chemical Society.
[35] Sabrina Pricl,et al. Self-assembled multivalent RGD-peptide arrays--morphological control and integrin binding. , 2013, Organic & biomolecular chemistry.
[36] David K Smith,et al. Self-assembling ligands for multivalent nanoscale heparin binding. , 2011, Angewandte Chemie.
[37] E. W. Meijer,et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[38] Daniel J. Welsh,et al. "On-off" multivalent recognition: degradable dendrons for temporary high-affinity DNA binding. , 2009, Angewandte Chemie.
[39] M. Nybo,et al. Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. , 2008, Basic & clinical pharmacology & toxicology.
[40] G. Montalescot,et al. Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep. , 1990, Circulation.
[41] Shawn C. Owen,et al. Stability of Self-Assembled Polymeric Micelles in Serum , 2011, Macromolecules.
[42] L. Brunsveld,et al. Supramolecular chemical biology; bioactive synthetic self-assemblies. , 2013, Organic & biomolecular chemistry.
[43] R. Duncan,et al. Dendrimer biocompatibility and toxicity. , 2005, Advanced drug delivery reviews.
[44] Jiaming Zhuang,et al. Multi-stimuli responsive macromolecules and their assemblies. , 2013, Chemical Society reviews.
[45] A. Wunder,et al. Complexes of a modified low-molecular-weight heparin with protamine are predominantly cleared by a macrophage scavenger receptor-mediated process in rats. , 1995, The Journal of surgical research.
[46] George M Whitesides,et al. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.
[47] Paul M. Levine,et al. Crafting precise multivalent architectures , 2013 .
[48] Rod Balhorn,et al. The protamine family of sperm nuclear proteins , 2007, Genome Biology.
[49] M. Klein,et al. The design and evaluation of heparin-binding foldamers. , 2005, Angewandte Chemie.
[50] Maurizio Fermeglia,et al. A simple new competition assay for heparin binding in serum applied to multivalent PAMAM dendrimers. , 2013, Chemical communications.
[51] Luc Brunsveld,et al. Combining supramolecular chemistry with biology. , 2010, Chemical Society reviews.
[52] Elizabeth R Gillies,et al. Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. , 2002, Journal of the American Chemical Society.
[53] R. Haag,et al. Degradable self-assembling dendrons for gene delivery: experimental and theoretical insights into the barriers to cellular uptake. , 2011, Journal of the American Chemical Society.
[54] F. Ahsan,et al. Synthesis and Evaluation of Pegylated Dendrimeric Nanocarrier for Pulmonary Delivery of Low Molecular Weight Heparin , 2009, Pharmaceutical Research.
[55] R. La Spina,et al. Polycationic calix[8]arenes able to recognize and neutralize heparin. , 2006, Organic & biomolecular chemistry.
[56] N. Voelcker,et al. Novel glycodendrimers self-assemble to nanoparticles which function as polyvalent ligands in vitro and in vivo. , 2002, Angewandte Chemie.
[57] F. Szoka,et al. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas , 2006, Proceedings of the National Academy of Sciences.
[58] R. Barbucci,et al. Chemistry and Biology of Glycosaminoglycans in Blood Coagulation , 1996 .
[59] T. Mecca,et al. Polycationic calix[8]arene receptors grafted onto polymeric matrix: smart material for heparin neutralization , 2010 .
[60] P. Rossmann,et al. Protamine-heparin aggregates , 1982, Virchows Archiv. B, Cell pathology including molecular pathology.